By recognizing homologous antigens, CD8+ Trm cells in the tumor microenvironment (TME) can rapidly secrete cytokines to activate innate immune cells and enhance the expression of chemokines and adhesion receptors, which in turn recruit circulating immune cells needed to exert essential antitumor functions. This evidence concerns the gene CD8A and neoplasm.